Ongoing monitoring and review of stable COPD
Review patients with chronic obstructive pulmonary disease (COPD) regularly; the frequency of review depends on the disease severity (symptoms and exacerbation history).
Suggested review intervals and assessments according to severity are outlined in Review intervals and suggested assessment of patients with COPD according to severity.
At each review, consider whether any change (step up or step down) of therapy is required.
The COPD Assessment Test (CAT) and the modified Medical Research Council (mMRC) dyspnoea scale are useful to assess changes in quality of life, breathlessness and functional limitation, and can help to quantify the patient’s perception of treatment adequacy.
Mild to moderate COPD [NB1] |
Review at least annually [NB2] Assess:
Measure:
|
Severe COPD [NB1] |
Review at least twice per year [NB2] Assess as for mild to moderate COPD, plus:
Measure as for mild to moderate COPD, plus:
|
Note:
BMI = body mass index; CAT = COPD Assessment Test; COPD = chronic obstructive pulmonary disease; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; mMRC = modified Medical Research Council; SpO2 = oxygen saturation measured by pulse oximetry NB1: See Classification of stable COPD severity for classification of COPD severity. NB2: More frequent opportunistic assessment of factors such as inhaler technique, smoking status, symptom control and adverse effects of treatment is encouraged. NB3: Perform spirometry annually in all patients with COPD. NB4: The CAT is available here. NB5: The mMRC dyspnoea scale is available here. |